Heterocyclic compound
US9598398B2 · kind B2 · utility
3Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2014 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Apr 3, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a compound represented by the formula (I), which is useful as an agent for the prophylaxis or treatment of epilepsy, neurodegenerative disease and the like. In the formula (I), each symbol is as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.